2008
DOI: 10.1016/j.toxlet.2007.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Exposure-triggered reproductive toxicity testing under the REACH legislation: A proposal to define significant/relevant exposure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
30
0
2

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 15 publications
2
30
0
2
Order By: Relevance
“…Moving away from the cancer bioassays, analyzing a reference database of more than 600 substances tested in more than 2,900 sub-chronic and chronic toxicity studies, Munro et al (1990Munro et al ( , 1996Munro et al ( , 1999 Cheeseman et al, 1999;Felter et al, 2009;Müller et al, 2006 General toxicity 0.025 -1 (depending on Cramer classes) Munro et al, 1996Munro et al, , 1999 Munro et al, 1996Munro et al, , 1999Escher et al, 2010;Bernauer et al, 2008Genotoxicity 0.025 -2 Rulis 1986, 1989Kroes et al, 2005;Müller et al, 2006 Carcinogenicity (genotoxic) 0.0025 Kroes et al, 2005;Cheeseman et al, 1999 Carcinogenicity (non-genotoxic) 0.025 -0.75 Kroes et al, 2005; (depending on Ames test and acute toxicity) Cheeseman et al, 1999 Acute toxicity (inhalation) 4 -1,000 μg/m 3 Grant et al, 2007;Escher et al, 2010 Neurotoxicity 0.3 Munro andKroes, 1998;Kroes et al, 2000 Developmental toxicity 1 a -8 -131 Munro and Kroes, 1998; (depending on Cramer class) Bernauer et al, 2008;0.5 -1 μg/m 3 (inhalation) van Ravenzwaay et al, 2011;Laufersweiler et al 2012 Reproductive toxicity 1 -100 Bernauer et al, 2008;van Ravenzwaay et al, 2011van Ravenzwaay et al, , 2012van Ravenzwaay et al, , 2017 Estrogenic endocrine disruption 0.025 Kroes et al, 2000 Immunotoxicity 0.15 -1,000 Kroes et al, 2000;Hartung and Corsini, 2013 Skin sensitization (dermal) 0.91 -900 μg/cm 2 Sa...…”
Section: IImentioning
confidence: 99%
See 4 more Smart Citations
“…Moving away from the cancer bioassays, analyzing a reference database of more than 600 substances tested in more than 2,900 sub-chronic and chronic toxicity studies, Munro et al (1990Munro et al ( , 1996Munro et al ( , 1999 Cheeseman et al, 1999;Felter et al, 2009;Müller et al, 2006 General toxicity 0.025 -1 (depending on Cramer classes) Munro et al, 1996Munro et al, , 1999 Munro et al, 1996Munro et al, , 1999Escher et al, 2010;Bernauer et al, 2008Genotoxicity 0.025 -2 Rulis 1986, 1989Kroes et al, 2005;Müller et al, 2006 Carcinogenicity (genotoxic) 0.0025 Kroes et al, 2005;Cheeseman et al, 1999 Carcinogenicity (non-genotoxic) 0.025 -0.75 Kroes et al, 2005; (depending on Ames test and acute toxicity) Cheeseman et al, 1999 Acute toxicity (inhalation) 4 -1,000 μg/m 3 Grant et al, 2007;Escher et al, 2010 Neurotoxicity 0.3 Munro andKroes, 1998;Kroes et al, 2000 Developmental toxicity 1 a -8 -131 Munro and Kroes, 1998; (depending on Cramer class) Bernauer et al, 2008;0.5 -1 μg/m 3 (inhalation) van Ravenzwaay et al, 2011;Laufersweiler et al 2012 Reproductive toxicity 1 -100 Bernauer et al, 2008;van Ravenzwaay et al, 2011van Ravenzwaay et al, , 2012van Ravenzwaay et al, , 2017 Estrogenic endocrine disruption 0.025 Kroes et al, 2000 Immunotoxicity 0.15 -1,000 Kroes et al, 2000;Hartung and Corsini, 2013 Skin sensitization (dermal) 0.91 -900 μg/cm 2 Sa...…”
Section: IImentioning
confidence: 99%
“…Munro et al (1996) used the 5 th percentiles of the lowest NOEL for each substance tested in chronic studies; NOELs of sub-chronic studies were divided by 3; and they then applied an additional assessment factor of 100. Bernauer et al, (2008), in contrast, used the lowest value and applied a safety factor of 100-1,000. The resulting TTC values are given in Table 3.…”
Section: Threshold Setting In Toxicologymentioning
confidence: 99%
See 3 more Smart Citations